The characteristics of the immune cell profiles in peripheral blood in cholangiocarcinoma patients.

Akihiko KidaEishiro MizukoshiHidenori KidoTadashi ToyamaTakeshi TerashimaKuniaki AraiTatsuya YamashitaKazumi FushimiTaro YamashitaYoshio SakaiMasao HondaAkio UchiyamaAkito SakaiKoichi ShimizuShuichi Kaneko

Published in: Hepatology international (2021)

The ICP in CCA are specifically attributable to cholangiocarcinoma, and may be biomarkers for therapeutic effects and prognoses.

Keyphrases

peripheral blood
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes